These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7975840)

  • 1. Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain.
    Tijhaar EJ; Zheng-Xin Y; Karlas JA; Meyer TF; Stukart MJ; Osterhaus AD; Mooi FR
    Vaccine; 1994 Aug; 12(11):1004-11. PubMed ID: 7975840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of recombinant avirulent vaccine strains in vivo.
    Curtiss R; Galan JE; Nakayama K; Kelly SM
    Res Microbiol; 1990; 141(7-8):797-805. PubMed ID: 1966252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity.
    Hohmann EL; Oletta CA; Loomis WP; Miller SI
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2904-8. PubMed ID: 7708746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.
    Dunstan SJ; Simmons CP; Strugnell RA
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):111-9. PubMed ID: 12832114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae.
    John M; Crean TI; Calderwood SB; Ryan ET
    Infect Immun; 2000 Mar; 68(3):1171-5. PubMed ID: 10678922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
    Chen D; Ma Q
    Chin J Biotechnol; 1997; 13(1):43-50. PubMed ID: 9376506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice.
    Ervin SE; Small PA; Gulig PA
    Microb Pathog; 1993 Aug; 15(2):93-101. PubMed ID: 8255210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains.
    Strugnell RA; Maskell D; Fairweather N; Pickard D; Cockayne A; Penn C; Dougan G
    Gene; 1990 Mar; 88(1):57-63. PubMed ID: 2187747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.
    Fouts TR; Tuskan RG; Chada S; Hone DM; Lewis GK
    Vaccine; 1995 Dec; 13(17):1697-705. PubMed ID: 8719522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A chromosomal integration system for development of polyvalent vaccine strains].
    Tu HL; Li SQ; Dong ZZ; Zhang ZS
    Yi Chuan Xue Bao; 1998 Dec; 25(6):551-8. PubMed ID: 10465899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
    Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
    Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and delivery of tetanus toxin fragment C fused to the N-terminal domain of SipB enhances specific immune responses in mice.
    Jang JI; Kim JS; Eom JS; Kim HG; Kim BH; Lim S; Bang IS; Park YK
    Microbiol Immunol; 2012 Sep; 56(9):595-604. PubMed ID: 22708880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vibrio cholerae toxin B subunit gene expressed in a Salmonella vaccine strain].
    Tian J; Lu D
    Wei Sheng Wu Xue Bao; 1992 Oct; 32(5):320-7. PubMed ID: 1362309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine.
    Chatfield SN; Charles IG; Makoff AJ; Oxer MD; Dougan G; Pickard D; Slater D; Fairweather NF
    Biotechnology (N Y); 1992 Aug; 10(8):888-92. PubMed ID: 1368983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity.
    Haddad D; Liljeqvist S; Kumar S; Hansson M; Ståhl S; Perlmann H; Perlmann P; Berzins K
    FEMS Immunol Med Microbiol; 1995 Dec; 12(3-4):175-86. PubMed ID: 8745001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.